ArentFox Schiff’s Pat Naples discusses with Medical Economics the US Centers for Medicare & Medicaid Services’ (CMS) expanded anti‑fraud enforcement and its impact on health care providers.
Michelle J. Shapiro to speak at Executive Women in Bio (EWIB) virtual program – Implementing Lessons Learned From Enforcement Developments to Improve Corporate Compliance.
On March 9, a federal court in Connecticut issued a decision in Abira Medical Laboratories LLC v. Aetna Inc. et al. that underscores the continuing importance of clear and comprehensive assignment-of-benefits language in payer disputes.
ArentFox Schiff, in collaboration with Consilio, will host the 2026 Chicago Pharma Forum on May 6, 2026, bringing together pharmaceutical industry leaders and in‑house counsel in the Chicago area for a full day of discussion and networking.
Health Care Industry Group Co-Leader Annie Chang Lee will kick off the California Ambulatory Surgery Association’s (CASA) Administrator Mastery Series as the inaugural speaker on March 25, 2026.
Health Care Industry Co-Leader Nadia Patel was quoted on Johnson & Johnson’s Janssen Products LP unit’s appeal to the Third Circuit Court of Appeals to overturn the 2025 jury $1.6 billion verdict — the largest False Claims Act (FCA) judgment in history.
As we continue to move through 2026, the life sciences landscape is shaped by a convergence of regulatory, enforcement, and market access developments that demand heightened attention from industry stakeholders.
Join attorneys Linda Jackson, Douglas Grimm, Jeff Weston, and Pat Naples as they address recent developments affecting the use of noncompete agreements in the health care industry.
The rapidly expanding consumer biomarker testing market — a major pillar of the longevity ecosystem — has produced its first major lawsuit between competitors.
The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.
ArentFox Schiff’s recently launched Longevity & Healthspan Industry Group and Group Leader Gayland O. Hethcoat II were featured by Longevity.Technology in an article about how the emergence of longevity-focused legal counsel is a maturity marker for the field.
The Centers for Medicare & Medicaid Services (CMS) has released detailed payment amounts, performance targets, and reporting requirements for the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, applicable to care periods beginning July 5 through December 31, 2027.
The healthcare group purchasing industry continues to provide critical market savings to hospitals, nursing homes, and medical practices throughout the United States – even as a panoply of issues place undue strain on healthcare supply chains – according to the 20th Annual Report of the Healthcare Group Purchasing Industry Initiative (HGPII).
On February 3, President Trump signed a $1.2 trillion funding package into law just hours after the House passed the Senate’s amended version of the FY2026 appropriations package, H.R. 7148, ending a brief partial government shutdown that began in the early hours of January 31.